37:
30:
405:
15:
448:
532:
527:
422:
410:
378:
205:
274:
50:
176:
232:
452:
329:
416:
319:
266:
198:
186:
152:
89:
521:
462:
391:
359:
353:
128:
98:
46:
343:
313:
193:
144:
62:
386:
339:
323:
308:
123:
118:
363:
303:
241:
212:
167:
113:
108:
103:
80:
333:
298:
251:
246:
222:
71:
58:
54:
349:
256:
490:
will show the template collapsed, i.e. hidden apart from its title bar.
455:), it is hidden apart from its title bar; if not, it is fully visible.
294:
148:
447:, meaning that if there is another collapsible item on the page (a
19:
514:
will show the template expanded, i.e. fully visible.
493:
469:
377:
287:
265:
231:
175:
166:
137:
88:
79:
70:
458:To change this template's initial visibility, the
31:
8:
172:
85:
76:
38:
24:
16:
442:initial visibility currently defaults to
459:
7:
453:table with the collapsible attribute
14:
1:
549:
400:
498:Agents against amoebozoa
474:Agents against amoebozoa
53: – agents against
206:Diiodohydroxyquinoline
533:Drug templates by ATC
528:Antiprotozoal agents
51:antiprotozoal agents
427:Never to phase III
168:Luminal amebicides
437:
436:
373:
372:
283:
282:
233:Dichloroacetamide
162:
161:
81:Tissue amebicides
540:
513:
512:
508:
505:
502:
499:
496:
489:
488:
484:
481:
478:
475:
472:
461:
460:|state=
445:
440:This template's
177:Hydroxyquinoline
173:
86:
77:
40:
33:
26:
17:
548:
547:
543:
542:
541:
539:
538:
537:
518:
517:
510:
506:
503:
500:
497:
494:
486:
482:
479:
476:
473:
470:
449:navbox, sidebar
443:
438:
433:
432:
417:Clinical trials
396:
369:
288:Other/ungrouped
279:
261:
227:
216:
158:
133:
66:
44:
12:
11:
5:
546:
544:
536:
535:
530:
520:
519:
516:
515:
491:
435:
434:
431:
430:
429:
428:
425:
414:
408:
402:
401:
398:
397:
395:
394:
389:
383:
381:
375:
374:
371:
370:
368:
367:
357:
347:
337:
327:
320:phenanthroline
317:
311:
306:
301:
291:
289:
285:
284:
281:
280:
278:
277:
271:
269:
267:Aminoglycoside
263:
262:
260:
259:
254:
249:
244:
238:
236:
229:
228:
226:
225:
218:
217:
209:
202:
199:Broxyquinoline
196:
190:
187:Chlorquinaldol
182:
180:
170:
164:
163:
160:
159:
157:
156:
153:Dehydroemetine
141:
139:
135:
134:
132:
131:
126:
121:
116:
111:
106:
101:
95:
93:
90:Nitroimidazole
83:
74:
68:
67:
47:Antiparasitics
45:
43:
42:
35:
28:
20:
13:
10:
9:
6:
4:
3:
2:
545:
534:
531:
529:
526:
525:
523:
492:
468:
467:
466:
465:may be used:
464:
456:
454:
450:
446:
426:
424:
421:
420:
418:
415:
412:
409:
407:
404:
403:
399:
393:
392:Chlorhexidine
390:
388:
385:
384:
382:
380:
376:
365:
361:
360:sesquiterpene
358:
355:
354:Tenonitrozole
351:
348:
345:
341:
338:
335:
331:
330:aminoacridine
328:
325:
321:
318:
315:
312:
310:
307:
305:
302:
300:
296:
293:
292:
290:
286:
276:
273:
272:
270:
268:
264:
258:
255:
253:
250:
248:
245:
243:
240:
239:
237:
234:
230:
224:
220:
219:
214:
210:
207:
203:
200:
197:
195:
191:
188:
184:
183:
181:
178:
174:
171:
169:
165:
154:
150:
146:
143:
142:
140:
136:
130:
129:Propenidazole
127:
125:
122:
120:
117:
115:
112:
110:
107:
105:
102:
100:
99:Metronidazole
97:
96:
94:
91:
87:
84:
82:
78:
75:
73:
69:
64:
60:
56:
52:
48:
41:
36:
34:
29:
27:
22:
21:
18:
457:
444:autocollapse
441:
439:
379:Acanthamoeba
344:Trimetrexate
314:Glycobiarsol
194:Tilbroquinol
145:isoquinoline
23:
413:from market
387:Propamidine
340:quinazoline
324:Phanquinone
309:Difetarsone
275:Paromomycin
235:derivatives
179:derivatives
124:Azanidazole
119:Secnidazole
92:derivatives
522:Categories
364:Fumagillin
304:Carbarsone
242:Diloxanide
213:Clioquinol
114:Nimorazole
109:Ornidazole
104:Tinidazole
485:collapsed
463:parameter
423:Phase III
411:Withdrawn
334:Mepacrine
299:Arsthinol
252:Etofamide
247:Clefamide
223:Chiniofon
221:related:
72:Entamoeba
59:amebicide
55:amoebozoa
509:expanded
350:thiazole
257:Teclozan
49: –
295:arsenic
211:I, Cl (
149:Emetine
406:WHO-EM
504:state
480:state
451:, or
138:Other
192:Br (
185:Cl (
204:I (
63:P01
524::
511:}}
495:{{
487:}}
471:{{
419::
507:=
501:|
483:=
477:|
366:)
362:(
356:)
352:(
346:)
342:(
336:)
332:(
326:)
322:(
316:)
297:(
215:)
208:)
201:)
189:)
155:)
151:/
147:(
65:)
61:(
57:/
39:e
32:t
25:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.